(Q34007711)

English

Evaluation of the effects of urotensin II and soluble epoxide hydrolase inhibitor on skin microvessel tone in healthy controls and heart failure patients

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Evaluation of the effects of urotensin II and soluble epoxide hydrolase inhibitor on skin microvessel tone in healthy controls and heart failure patients (English)

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

1 reference

based on heuristic

inferred from title

Soluble epoxide hydrolase

0 references

4

object named as

Henry Krum

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

author name string

Lavinia Tran

1

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Andrew R Kompa

2

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Bing H Wang

3

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

publication date

4 August 2011

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Cardiovascular Therapeutics

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

30

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

5

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

295-300

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Human urotensin-II is a potent vasoconstrictor and agonist for the orphan receptor GPR14

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5922.2011.00282.X

21 January 2018

Congestive heart failure and expression of myocardial urotensin II.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5922.2011.00282.X

21 January 2018

Elevated plasma levels of human urotensin-II immunoreactivity in congestive heart failure

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5922.2011.00282.X

21 January 2018

Increased plasma urotensin II levels in patients with diabetes mellitus

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5922.2011.00282.X

21 January 2018

Chronic urotensin-II infusion induces diastolic dysfunction and enhances collagen production in rats.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5922.2011.00282.X

21 January 2018

Urotensin II and atherosclerosis.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5922.2011.00282.X

21 January 2018

Human urotensin II accelerates foam cell formation in human monocyte-derived macrophages

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5922.2011.00282.X

21 January 2018

Differential effect of urotensin II on vascular tone in normal subjects and patients with chronic heart failure

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5922.2011.00282.X

21 January 2018

Effect of exogenous urotensin-II on vascular tone in skin microcirculation of patients with essential hypertension

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5922.2011.00282.X

21 January 2018

Effect of urotensin II on skin microvessel tone in diabetic patients without heart failure or essential hypertension.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5922.2011.00282.X

21 January 2018

Epoxide hydrolases: their roles and interactions with lipid metabolism

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5922.2011.00282.X

21 January 2018

Identification of epoxyeicosatrienoic acids as endothelium-derived hyperpolarizing factors

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5922.2011.00282.X

21 January 2018

The Soluble Epoxide Hydrolase Inhibitor AR9281 Decreases Blood Pressure, Ameliorates Renal Injury and Improves Vascular Function in Hypertension

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5922.2011.00282.X

21 January 2018

Soluble epoxide hydrolase inhibition lowers arterial blood pressure in angiotensin II hypertension

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5922.2011.00282.X

21 January 2018

Soluble epoxide hydrolase is a main effector of angiotensin II-induced hypertension

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5922.2011.00282.X

21 January 2018

Soluble epoxide hydrolase inhibitor, AUDA, prevents early salt-sensitive hypertension

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5922.2011.00282.X

21 January 2018

Targeted disruption of soluble epoxide hydrolase reveals a role in blood pressure regulation

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5922.2011.00282.X

21 January 2018

Identifiers

10.1111/J.1755-5922.2011.00282.X

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34007711&oldid=1982391717"